Satisfaction After Glaucoma Surgery in Rural China

Sponsor
Sun Yat-sen University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT02629237
Collaborator
(none)
0
1
2
31
0

Study Details

Study Description

Brief Summary

  1. Investigate degree of postoperative satisfaction in county level hospital glaucoma patients.

  2. Investigate the effect of educational intervention affect the degree of satisfaction in glaucoma patients.

  3. Investigate the effect factors of postoperative satisfaction.

Condition or Disease Intervention/Treatment Phase
  • Other: Multifaceted education
N/A

Detailed Description

Glaucoma is the leading cause of irreversible blindness in China, as elsewhere in the world. In Chinese rural settings, where topical glaucoma medication is unlikely to be a practical and sustainable option, surgery is the primary treatment modality for glaucoma. However, it is known that vision is quite likely to decline in the short to medium term after glaucoma surgery, and there are concerns that dis-satisfaction resulting from such vision changes might lead to negative social marketing, affecting uptake not only of glaucoma surgical care but other eye operations (principally cataract) as well. We propose to test the impact on post-operative satisfaction of a multi-media educational intervention designed to give patients a realistic expectation of their post operative course: glaucoma surgery is being performed NOT to improve vision, but do protect it from future harm, and vision may in fact decline for several weeks post operatively. A randomized controlled design will be used, and subjects undergoing glaucoma surgery will be enrolled at 4 rural county hospitals in rural Guangdong province, and randomized to receive the intervention or usual care. The principal outcome will be subjective satisfaction on a previously-tested questionnaire instrument, administered pre-operatively and post-operatively on two occasions in the first month following surgery. Patients not returning post-operatively to the surgical facility will be contacted by telephone for administration of the questionnaire. Other facility- and patient-related clinical and personal factors expected to influence satisfaction will also be recorded, and adjusted for in all analyses.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Impact of Multifaceted Education on Satisfaction After Glaucoma Surgery in Rural China
Anticipated Study Start Date :
Mar 1, 2022
Anticipated Primary Completion Date :
Oct 1, 2024
Anticipated Study Completion Date :
Oct 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Multifaceted education group

Subjects will be asked to watch a 5-10 min education film and participate in a 10-15 min counseling session with a trained doctor/nurse before glaucoma surgery,and at 1 week and 2 week after surgery.

Other: Multifaceted education
Subjects will be asked to watch a 5-10 min education film and participate in a 10-15 min counseling session with a trained doctor/nurse before glaucoma surgery,and at 1 week and 2 week after surgery.

No Intervention: control group

Subjects will not be asked to watch education film and not participate in counseling session before and after surgery.

Outcome Measures

Primary Outcome Measures

  1. The mean satisfaction score over three follow-up visits [1 week, 2 week and 4 week after surgery.]

    The primary outcome is the mean satisfaction score calculated by adding up the satisfaction scores at three follow-up visits: 1 week, 2 week and 4 week after surgery and dividing the total by the number of scores. The satisfaction score was assessed as a cumulative score. Composite outcome, in which multiple end points are combined, are frequently used as primary outcome measures in randomized trials and are often associated with increased statistical efficiency, although such measure may prove challenging for the interpretation of results. (Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA. 2003; 289: 2554-2559)

Secondary Outcome Measures

  1. The rate of willingness to recommend surgery to a friend or relative with glaucoma [1 week, 2 week and 4 week after surgery.]

    The measurement method:questionnaire

  2. Personality in both groups using Eysenck Personality Questionnaire-Revised Short Scale for Chinese (EPQ-RSC) access glaucoma patients personality [before surgery]

  3. Knowledge scores about glaucoma [before surgery and 1 week, 2 week and 4 week after surgery]

  4. Intraocular pressure in both groups [before surgery and 1 week, 2 week and 4 week after surgery]

    Unit of Intraocular pressure is mmHg.

  5. visual acuity in both groups [before surgery and 1 week, 2 week and 4 week after surgery]

    Visual acuity testing use Snellen-based letter charts,such as a Snellen score of 6/12 (20/40), indicating an observer can resolve details as small 2 minutes of visual angle, corresponds to a LogMAR of 0.3 (since the base-10 logarithm of 2 is 0.3)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • age≥18 years, glaucoma patients who do the peripheral iridectomy or trabeculotomy
Exclusion Criteria:
  • patients who had been the trabeculotomy, vision≤0.05, severe psychotic disorders and dysgnosia

Contacts and Locations

Locations

Site City State Country Postal Code
1 Blindness Preventment and Treatment Department Guangzhou Guangdong China 510060

Sponsors and Collaborators

  • Sun Yat-sen University

Investigators

  • Principal Investigator: Nathan Congdon, MD,MPH, The Key Laboratory,Zhongshan Ophthalmic Center,Sun Yat-sen University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Congdon Nathan, vice directior,Blindness Prevention and Treatment Department, Sun Yat-sen University
ClinicalTrials.gov Identifier:
NCT02629237
Other Study ID Numbers:
  • ZOC-CREST-Satisfaction
First Posted:
Dec 14, 2015
Last Update Posted:
Sep 27, 2021
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Congdon Nathan, vice directior,Blindness Prevention and Treatment Department, Sun Yat-sen University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 27, 2021